Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic potential for microRNAs.

Christine C Esau1, Brett P Monia

  • 1Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, California 92008, USA. cesau@isisph.com

Advanced Drug Delivery Reviews
|April 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia.

Blood advances·2026
Same author

Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen.

Immunobiology·2025
Same author

TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.

Advances in therapy·2023
Same author

Targeting the contact system in a rabbit model of extracorporeal membrane oxygenation.

Blood advances·2022
Same author

CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway.

Nature communications·2022
Same author

In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis.

International journal of molecular sciences·2021

MicroRNAs (miRNAs) are key regulators of gene expression with emerging roles in diseases like cancer. Therapeutic strategies targeting miRNAs are under development for future treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are endogenous non-coding RNAs that regulate gene expression post-transcriptionally.
  • Emerging evidence highlights miRNA involvement in critical diseases, including cancer, metabolic disorders, and viral infections.
  • This suggests miRNAs represent a novel class of therapeutic targets.

Purpose of the Study:

  • To explore the biological roles of miRNAs.
  • To investigate the potential of miRNA-modulating technologies as therapeutic agents.
  • To project future advancements in miRNA biology and therapeutic applications.

Main Methods:

  • Antisense oligonucleotide (ASO) strategies to inhibit miRNA function.
  • Small interfering RNA (siRNA)-like technologies for miRNA replacement.

Related Experiment Videos

  • Ongoing research to uncover miRNA biology and therapeutic potential.

    • Main Results:

    • Accumulating examples demonstrate the significance of miRNAs in various diseases.
    • Antisense and siRNA-like technologies are being actively explored.
    • These approaches serve as tools for both understanding miRNA function and developing therapeutics.

    Conclusions:

    • MiRNAs are crucial regulators with significant implications in disease pathogenesis.
    • Therapeutic modulation of miRNA activity holds promise for treating various conditions.
    • Antisense and replacement strategies are advancing the field of miRNA therapeutics.